Japan's contribution to clinical pediatrics research in the last decade
- 30 January 2004
- journal article
- Published by Wiley in Pediatrics International
- Vol. 46 (1) , 1-4
- https://doi.org/10.1111/j.1328-0867.2004.01836.x
Abstract
Objective : To determine Japan's contribution to research in clinical pediatrics over the last decade. Methods : Articles published in highly reputable pediatrics journals from 1991−2000 were accessed through the MEDLINE database. The number of articles which had an affiliation with a Japanese institution were counted for each of the journals and also summed in total. Proportions of randomized controlled trials (RCTs) and case‐control/cohort studies among the articles from Japan were also generated and compared with the average for the entirety. In addition, shares of the top‐ranking countries were presented along with their trend over time. Results : In total, 20 189 articles were published in the selected seven pediatric journals from 1991−2000. Japan contributed 3.0% of these articles and this contribution was ranked 7th in the world. A negative trend was noticed in Japan's contribution over time but it was not statistically significant (z = −0.40, P = 0.16). RCTs accounted for 7.3% of the total articles, but only 0.34% of those from Japan. Conclusions : Japan's share of articles in pediatrics research was smaller than that in basic science and some of the other clinical fields. The number of articles from Japan providing a high level of evidence was meager in this field.Keywords
This publication has 16 references indexed in Scilit:
- Publications in Epidemiology Journals: Japanese perspectives.Journal of Epidemiology, 2007
- Share of research output in dermatology: a quantitative ranking.British Journal of Dermatology, 2003
- Japan's contribution to research in rheumatologyModern Rheumatology, 2003
- Comparison of Yatabe-Guilford Personality Test Results in Retinitis Pigmentosa and Glaucoma PatientsJapanese Journal of Ophthalmology, 2003
- Thrombocytopenia Induced by Imatinib Mesylate (Glivec) in Patients with Chronic Myelogenous Leukemia: is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?International Journal of Hematology, 2003
- Japan’s share of articles in orthopedicsJournal of Orthopaedic Science, 2002
- Research output in anaesthesia: a quantitative rankingAnaesthesia, 2002
- A Decline in the U.S. Share of Research ArticlesNew England Journal of Medicine, 2002
- Contribution of Research in Basic and Clinical Sciences in Japan.Internal Medicine, 2002
- Forefront of medical science and medical care.Procedure and significance of evidence-based medicine.Nihon Naika Gakkai Zasshi, 1998